TD Asset Management Inc

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1056053 Toronto, A6

Position in MDGL

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$4,904,501

-$1,425,298 QoQ

Shares Held

9,134

-24.5% QoQ

Ownership

0.040%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#119

of 411 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. MDGL ranks #45 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	259,317	$161,694,522
2	VRTX	Vertex Pharmaceuticals Inc / Ma	207,960	$103,299,970
3	HALO	Halozyme Therapeutics, Inc.	1,115,730	$87,328,187
4	ALNY	Alnylam Pharmaceuticals, Inc.	233,696	$70,349,506
5	CYTK	Cytokinetics Inc	385,130	$32,809,224
6	RPRX	Royalty Pharma plc	567,497	$31,819,556
7	ASND	Ascendis Pharma A/S	119,085	$31,762,351
8	KYMR	Kymera Therapeutics, Inc.	272,900	$31,293,443

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,904,501	9,134	-24.5%	Shares	Sole	2026-08-04
2026-03-31	$6,329,799	12,092	+16.4%	Shares	Sole	2026-05-11
2025-12-31	$6,048,183	10,386	-22.1%	Shares	Sole	2026-02-10
2025-09-30	$6,111,185	13,324	-42.7%	Shares	Sole	2025-11-10
2025-06-30	$7,033,353	23,240	+4.5%	Shares	Sole	2025-07-28
2025-03-31	$7,366,555	22,240	-15.5%	Shares	Sole	2025-05-07
2024-12-31	$8,124,648	26,330	-30.9%	Shares	Sole	2025-02-11
2024-09-30	$8,091,948	38,130	-31.6%	Shares	Sole	2024-11-01
2024-06-30	$15,613,316	55,730	+10.7%	Shares	Sole	2024-08-02
2024-03-31	$13,440,123	50,330	+223.9%	Shares	Sole	2024-05-08
2023-12-31	$3,595,645	15,540	+223.7%	Shares	Sole	2024-02-12
2020-12-31	$533,616	4,800	0.0%	Shares	Sole	2021-02-16
2020-09-30	$569,904	4,800	+49.8%	Shares	Sole	2020-11-10
2020-06-30	$362,966	3,205	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.